title: Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma.
authors.affiliation: Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
authors.forename: Piers
authors.initials: P
authors.lastname: Blombery
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
authors.forename: Michele
authors.initials: M
authors.lastname: Levinson
authors.forename: Stephen
authors.initials: S
authors.lastname: Pianko
authors.forename: Ellen
authors.initials: E
authors.lastname: Maxwell
authors.forename: Prithi
authors.initials: P
authors.lastname: Bhathal
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018951:Antigens, CD20 / Q000502:physiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003424:Crohn Disease / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D018928:Immunity, Mucosal; D008214:Lymphocytes / Q000502:physiology*; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab